OR29-3 High-specific-activity Iodine 131 Metaiodobenzylguanidine for the Treatment of Advanced Pheochromocytoma and Paraganglioma: A Real-world Study

INTRODUCTION: Metastatic pheochromocytomas/paragangliomas (mPPGLs) are rare tumors with limited treatment options. High-specific-activity 131I-meta-iodobenzylguanidine (HSA 131I-MIBG) is the only approved therapy for mPPGLs. We summarized the efficacy and safety profile of HSA 131I-MIBG in patients...

Descripción completa

Detalles Bibliográficos
Autor principal: Al-ward, Ruaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628076/
http://dx.doi.org/10.1210/jendso/bvac150.1823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628076/
http://dx.doi.org/10.1210/jendso/bvac150.1823

Ejemplares similares